Olga Osipova

Olga Osipova

Auto-generated profile, based on publicly available information

Olga Osipova

Institute of Chemistry, St. Petersburg State University, Universitetskii pr. 26, Peterhof, 198504 St. Petersburg, Russia

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 January 2020 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
OOOlga Osipova
Olga Osipova
Vladimir SharoykoVladimir Sharoyko
Vladimir Sharoyko
NZNatalia Zashikhina
Natalia Zashikhina
NZNataliya V. Zakharova
Nataliya V. Zakharova
Tatiana TennikovaTatiana Tennikova
Tatiana Tennikova
Evgenia Korzhikova-VlakhEvgenia Korzhikova-Vlakh
Evgenia Korzhikova-Vlakh
Polyethyleneimine, poly-L-lysine, chitosan and some others cationic polymers have been thoroughly studied as nucleic acid delivery systems in gene therapy. However, the drug release from these systems proceeds at a very low rate due to extremely high binding between a carrier and gene material. To reduce these interactions and to enhance drug release, we developed a set of amphiphilic polypeptides containing positively and negatively charged amino acids as well as a hydrophobic one. The copolymers obtained were characterized by size-exclusion chromatography, static light scattering, HPLC amino acid analysis and 1HNMR spectroscopy. All copolymers formed particles due to a self-assembly in aqueous media. Depending on polypeptide composition, the formation of particles with hydrodynamic diameters from 180 to 900 nm was observed. Stability of polymer particles, loading and release efficiency were carefully studied. Cellular uptake of the particles was efficient and their cytotoxicity was negligible. The application of polymer carriers, containing siRNA, to vascular endothelial growth factor (VEGF-A165) silencing of ARPE-19 cells was successful. The gene silencing was confirmed by suppression of both messenger RNA and protein expression.

Verified
Journal Article
Open access
PDF file
IPIuliia Pilipenko
Iuliia Pilipenko
OKOlga Korovkina
Olga Korovkina
NGNina Gubina
Nina Gubina
VEViktoria Ekimova
Viktoria Ekimova
AIAnastasia Ishutinova
Anastasia Ishutinova
Viktor Korzhikov-VlakhViktor Korzhikov-Vlakh
Viktor Korzhikov-Vlakh
Messenger RNA (mRNA) is currently of great interest as a new category of therapeutic agent, which could be used for prevention or treatment of various diseases. For this mRNA requires effective delivery systems that will protect it from degradation, as well as allow cellular uptake and mRNA release. Random poly(lysine-co-isoleucine) polypeptides were synthesized and investigated as possible carriers for mRNA delivery. The polypeptides obtained under lysine:isoleucine monomer ratio equal to 80/20 were shown to give polyplexes with smaller size, positive ζ-potential and more than 90% encapsulation efficacy. The phase inversion method was proposed as best way for encapsulation of mRNA into polyplexes, which are based on obtained amphiphilic copolymers. These copolymers showed efficacy in protection of bound mRNA towards ribonuclease and lower toxicity as compared to lysine homopolymer. The poly(lysine-co-isoleucine) polypeptides showed greater than poly(ethyleneimine) efficacy as vectors for transfection of cells with green fluorescent protein and firefly luciferase encoding mRNAs. This allows us to consider obtained copolymers as promising candidates for mRNA delivery applications.